{"transactions":[{"id":1825823,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":136846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":136846,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Series A Common Stock","underlying_shares":136846},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}},{"id":1825822,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":136846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":136846},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}},{"id":1825821,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":9286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":9286,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":9286},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}},{"id":1825820,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":9286},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}},{"id":1825819,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":111438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":111438,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":111438},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}},{"id":1825818,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":58521,"kind":"person","name":"Hom Dennis","position":1,"cik":"0001600362","reported_name":"Hom Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:16:22.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":111438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":111438},"source":{"system":"sec-edgar","filing":"0001104659-23-082724","document":"tm2321276-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600362/000110465923082724/tm2321276-15_4seq1.xml","form_type":"4"}}]}